CMN 568 -Unit 3 Combo
For moderate persistent asthma, symptoms occur - answerDaily
For moderate persistant asthma, SABA use is - answerDaily
For moderate persistant asthma, nighttime awakenings ages 0-4 - answer3-4
times/month
For moderate persistant asthma, nighttime awakenings for >5 - answer> once a week,
not nightly
For moderate persistant asthma, interference with normal activity - answerSome
For moderate persistant asthma, Lung function FEV1 or PEF (personal best), >12 -
answer60-80&
For moderate persistant asthma, FEV1/FVC, ages 5-11 - answer75-80%
For moderate persistant asthma, FEV1/FVC ages over 12 - answerless than 5%
For moderate persistant asthma, exacerbations requiring oral corticosteroids, ages 0-4 -
answer>=2times/6 months or >= 4 wheezing episodes in a year that last longer than a
day AND risk factors for persistent asthma.
For moderate persistant asthma, exacerbations requiring oral corticosteroids, >= 5
years - answer>= 2 times/year of exacerbations
For moderate persistant asthma, exacerbations, recommended step for starting
treatment - answerStep 3 and reevaluate in 2-6 weeks
After starting treatment for asthma, you should reevaluate the patient in - answer2-6
weeks
When is treatment not appropriate when using SABAs PRN? - answerWhen more than
1 canister/month is used
Can LABAs be used as mono therapy? - answerNo, administer with ICS
What is the action of Theophylline? - answerrelaxes and opens airways, rarely used
because it requires careful monitoring
,How and why is Omalizumab given? - answerSub-q every 2-4 weeks; given to patients
over 12 with mod to persistent asthma with positive skin test.
What is the action of ICS? - answerprevent inflammation of the airways
What is the hallmark on CXR for miliary TB? - answerSnowstorm
Treatment of TB in pregnancy: - answer2 mos: INH, RIF, EMB
7 mos: INH, RIF
What drug cannot be used in pregnancy when treating TB? - answerPZA
Side effect of RIF? - answerOrange secretions
SIde effect of PZA? - answerHyperuricemia; hepatotoxicity - (reason not given in LTBI)
Side effect of EMB: - answeroptic neuritis
Side effect of INH: - answerPeripheral neuropathy
What drug is added to INH therapy? - answerVit B6
A false negative TB test can result in: - answermalnourished, overwhelming disease,
10% of kids
Does a negative TST exclude TB? - answerNo
You should consider COPD, and perform spirometry if any of these indicators are
present in an individual over age 40: - answerDyspnea (progressive, worse with
exercise, persistent daily, described as air hunger, gasping, etc), Chronic cough,
chronic sputum production, and history of exposure (tobacco smoke, occupational dusts
and chemicals, smoke from home cooking and heating fuel)
Diagnosis of COPD should be confirmed by - answerSpirometry and clinical symptoms
and signs
Why is a low peak flow inconsistent with diagnosing COPD? - answerpoor specificity;
low peak flow can be caused by other diseases and by poor performance
What drug is contraindicated in COPD and asthma? - answerBeta blockers
Stage III - Severe COPD has a FEV1 of - answerFEV1<50% predicted
Stage 1 - Mild COPD has a FEV1 of - answerFEV1> 80% predicted
Stage 4 - Very severe COPD has a FEV1 of - answerFEV1<30% predicted
,Stage 2 - Mod COPD has a FEV1 of - answerFEV1<80% predicted
All COPD patients have a FEV1/FEV of - answer<70% or 0.70
When are bronchodilators prescribed in COPD? - answerAs needed to relieve
intermittent or worsening symptoms, and on a regular basis to prevent or reduce
persistent symptoms
When are inhaled glucocorticoids prescribed in COPD? - answersymptomatic patients
with an FEV1<50% predicted and repeated exacerbations.
Mild COPD treatment - answerFlu vaccine,SABA
Mod COPD treatment - answerFlu vaccine, SABA, LABA, Rehab
Severe COPD treatment - answerFlu vaccine, SABA, LABA, Rehab, ICS
Very severe COPD treatment - answerFlu vaccine, SABA, LABA, Rehab, ICS, O2 (worn
15 hrs/daily)
SABAs: - answerLevalbuterol, Albuterol, Terbutaline, Fenoterol
LABAs: - answerFormoterol, Salmeterol, Indacaterol, Arformoterol
Anticholinergics: - answerIpratropium bromide
ICS: - answerBudenoside, Fluticasone, Beclomethasone
Systemic Glucocorticoids: - answerPrednisone, Methylprednisolone
Characteristics of Emphysema: - answerUsually over 50 y/o, insidious progressive
dyspnea, no cough, scant, clear sputum, hyperressonance, decreased breath sounds
Characteristics of chronic bronchitis - answerUsually over 35 y/o, recurrent cough, PFT
normal or decreased lung capacity with residual volume, sputum is copious
mucopurulent
Asthma > 12 yrs: Step 4 is treated with _____. - answerMedium dose ICS and LABA
Asthma > 12 yrs: Step 1 is treated with ____. - answerSABA PRN
Asthma >12 yrs: Step 3 is treated with ____. - answerLow dose ICS and LABA or Med
ICS
Asthma >12 yrs: Step 2 is treated with _____. - answerLow dose ICS
, Asthma > 12 yrs: Step 5 is treated with ____. - answerHigh dose ICS and LABA and
consider omalizumab
Asthma > 12 yrs: Step 6 is treated with____. - answerHigh dose ICS and LABA and oral
corticosteroid and consider omalizumab.
What is the isoniazid chemoprophylaxis treatment if exposed to TB? - answer10mg/kg/d
x 2 months after last contact, then Mantoux test, continue therapy for 7 months if
positive.
Symptoms of active disease in TB: - answerchronic cough, anorexia, wt loss or poor wt
gain, fever, night sweats (most children are asymptomatic)
Transmission of TB: - answerAirborne precautions...transmitted by respiratory droplets.
For moderate persistant asthma, symptoms occur - answerDaily
For moderate persistant asthma, SABA use is - answerDaily
For moderate persistant asthma, nighttime awakenings ages 0-4 - answer3-4
times/month
For moderate persistant asthma, nighttime awakenings for >5 - answer> once a week,
not nightly
For moderate persistant asthma, interference with normal activity - answerSome
For moderate persistant asthma, Lung function FEV1 or PEF (personal best), >12 -
answer60-80&
For moderate persistant asthma, FEV1/FVC, ages 5-11 - answer75-80%
For moderate persistant asthma, FEV1/FVC ages over 12 - answerless than 5%
For moderate persistant asthma, exacerbations requiring oral corticosteroids, ages 0-4 -
answer>=2times/6 months or >= 4 wheezing episodes in a year that last longer than a
day AND risk factors for persistent asthma.
For moderate persistant asthma, exacerbations requiring oral corticosteroids, >= 5
years - answer>= 2 times/year of exacerbations
For moderate persistant asthma, exacerbations, recommended step for starting
treatment - answerStep 3 and reevaluate in 2-6 weeks